07/01/2025
4:32 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
4:13 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
4:24 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
3:40 PM | Abbott Laboratories (Issuer)
Cushman Elizabeth C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2025
3:47 PM | Abbott Laboratories (Issuer)
Cushman Elizabeth C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
10:01 AM | Abbott Laboratories (Filer)
| Form SD
Specialized Disclosure Report | |
04/29/2025
5:30 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
4:49 PM | Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
4:58 PM | Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
5:06 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
5:14 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ABT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Abbott Laboratories and its competitors with MarketBeat's FREE daily newsletter. |
04/29/2025
5:22 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
4:19 PM | Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
4:30 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
4:40 PM | Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
3:10 PM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
4:39 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:30 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:05 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:55 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:28 PM | Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
4:47 PM | Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:54 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:05 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:33 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:39 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:44 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:21 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:27 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:00 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:40 PM | Abbott Laboratories (Subject)
Shroff Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:29 PM | Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/03/2025
6:58 PM | Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:08 PM | Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:18 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
6:52 PM | Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
5:47 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:56 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:07 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Critical AI announcement set to ignite AI 2.0 (Ad) I just put together an urgent new presentation that you need to see right away.
In short: I believe we are mere days away from a critical announcement from a key tech leader…
One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.  Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
02/27/2025
5:17 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:26 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:35 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:37 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:46 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
4:51 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
5:52 PM | Abbott Laboratories (Subject)
Ford Robert B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025
6:08 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
6:16 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:33 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:33 PM | Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
4:26 PM | Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
4:30 PM | Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
6:13 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
4:26 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
4:14 PM | Abbott Laboratories (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
4:10 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
6:37 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:27 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:33 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:39 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:48 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:24 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:20 PM | Abbott Laboratories (Subject)
Ford Robert B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:03 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:02 PM | Abbott Laboratories (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
6:37 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
